{"id":"W4414937175","doi":"10.51731/cjht.2025.1251","title":"Rozanolixizumab (Rystiggo)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Drug approval; Antibody therapy; Tyrosine kinase","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000868419,0.0002258132,0.0004009983,0.001017488,0.000139902,0.0006149313,0.0002813809,0.0003010233,0.003399912],"category_scores_gemma":[0.001043691,0.0000721157,0.0004822067,0.0009047756,0.0001900288,0.0002489993,0.0001636067,0.0003516528,0.0008665575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001501312,"about_ca_system_score_gemma":0.001868842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01727092,"about_ca_topic_score_gemma":0.06422088,"domain_scores_codex":[0.9994078,0.0001273803,0.00005489384,0.00004292778,0.0003142139,0.00005284635],"domain_scores_gemma":[0.9995127,0.0001187145,0.0001764461,0.00001126885,0.0001522962,0.00002859721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004439983,0.00005201161,0.00102609,0.008199898,0.0001953627,0.0001923128,0.0000363834,0.0001752545,0.005184902,0.001525579,0.02158604,0.9613822],"study_design_scores_gemma":[0.0003629967,0.001123681,0.017448,0.006678535,0.0006500094,0.001922051,0.00008778006,0.000178839,0.004919322,0.0004137756,0.9661871,0.0000278165],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.01107429,0.9545581,0.0007799112,0.001756988,0.0001938225,0.0001603225,0.00105057,0.00009238649,0.03033363],"genre_scores_gemma":[0.1213689,0.8559251,0.003636897,0.001793707,0.000197071,0.0001471379,0.001517842,0.00002273077,0.01539063],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01727092,"threshold_uncertainty_score":0.0343408,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01473510738698327,"score_gpt":0.28782373180524,"score_spread":0.2730886244182567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}